Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesBaird Medical Investment Holdings Limited

Baird Medical Investment Holdings Limited

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
0.1575 USD 0.05 ( 44.36%)
Last update at 2026-11-05T21:29:00Z
VOLUME
366355148
Market Cap
33.90M

Momentum Score

…

Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; and long and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, and uterine fibroids, as well as soft tissue ablation. It sells its products through third-party distributors. It has a strategic cooperation agreement with Tianjin Yuanshan Medical Technology Co., Ltd. to focus on global development and commercialization of next-generation IRE technologies. Baird Medical Investment Holdings Limited was founded in 2012 and is based in Guangzhou, China.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.10
Low
0.19
High
52 Week Price Range
0.76
Low
3.70
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
0.11
Dividend Yield
-
Revenue TTM
24.49M
Revenue Per Share
0.81
Gross Profit TTM
20.97M
Debt / Equity
0.62
ROE
-46.03%
Net Debt
19.12M
ROCE
-68.66%
Diluted EPS TTM
-0.55

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -26.37M 14.09M 12.36M 14.52M 12.61M
Minority interest 0.26M -0.14M -0.11M -0.21M -0.09M
Net income -27.28M 12.45M 10.55M 12.57M 11.68M
Selling general administrative 14.12M 5.90M 8.55M 6.96M 6.65M
Selling and marketing expenses 10.26M 4.06M 2.55M 3.59M 3.57M
Gross profit 18.88M 32.65M 27.23M 28.04M 23.18M
Reconciled depreciation 1.10M 1.51M 1.38M 1.47M 1.40M
Ebit -25.64M 14.66M 11.86M 14.82M 12.76M
Ebitda -24.53M 16.17M 12.88M 16.29M 14.16M
Depreciation and amortization 1.10M 1.51M 1.01M 1.47M 1.40M
Operating income -25.54M 15.32M 11.86M 13.63M 11.92M
Other operating expenses 48.07M 21.72M 19.60M 20.08M 14.63M
Interest expense 0.74M 0.58M 0.28M 0.30M 0.15M
Tax provision 1.17M 1.49M 1.70M 1.75M 2.42M
Interest income - 0.00M 0.00M 0.01M 0.00M
Net interest income -0.74M -0.58M -0.28M -0.29M -0.15M
Income tax expense 1.17M 1.49M 1.70M 1.75M 2.42M
Total revenue 22.54M 37.04M 31.46M 35.09M 27.72M
Total operating expenses 44.42M 17.34M 15.37M 13.03M 9.76M
Cost of revenue 3.65M 4.38M 4.23M 7.05M 4.54M
Total other income expense net -0.84M -1.23M 0.50M 0.89M 0.69M
Net income from continuing ops -27.54M 12.60M 10.66M 12.77M 10.18M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 69.70M 77.96M 56.71M 42.62M 26.12M
Intangible assets 0.01M 0.02M 0.03M 0.05M 0.06M
Other current assets 11.17M 10.57M 5.94M 6.00M 3.55M
Total liab 38.48M 38.20M 21.00M 16.84M 10.26M
Total stockholder equity 31.37M 39.66M 35.75M 25.93M 5.20M
Other current liab 13.48M 12.41M 7.67M 6.70M 5.54M
Common stock 0.00M 0.00M 0.00M 0.00M 0.01M
Capital stock 0.00M 0.00M 0.00M 0.00M 0.00M
Retained earnings -0.52M 26.76M 14.39M 3.96M -7.13M
Good will 0.06M 0.06M 0.06M 0.06M 0.07M
Cash 0.18M 2.97M 1.51M 1.71M 3.03M
Total current liabilities 32.36M 34.62M 18.98M 16.02M 9.77M
Current deferred revenue 0.79M 0.79M 0.50M 0.69M 0.70M
Net debt 19.12M 17.91M 8.39M 5.73M -0.10M
Short term debt 13.18M 17.30M 9.49M 6.62M 2.44M
Short long term debt 13.07M 17.03M 8.17M 6.23M 2.04M
Short long term debt total 19.30M 20.88M 9.90M 7.44M 2.93M
Other stockholder equity 28.66M 11.44M 18.85M 18.85M 9.01M
Total current assets 54.97M 61.42M 40.08M 33.76M 22.40M
Short term investments - 0.30M 0.12M 0.20M 0.41M
Net receivables 42.53M 46.58M 31.49M 24.76M 12.45M
Long term debt 6.09M 3.44M 1.61M - -
Inventory 1.09M 1.30M 1.14M 1.29M 3.06M
Accounts payable 1.81M 1.25M 0.55M 0.22M 0.34M
Accumulated other comprehensive income 3.22M 1.45M 2.50M 3.12M 3.31M
Non currrent assets other 7.35M 8.14M 10.36M 5.81M 0.19M
Non current assets total 14.73M 16.55M 16.63M 8.85M 3.72M
Capital lease obligations 0.14M 0.40M 3.35M 1.21M 0.89M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -2.85M -2.64M -5.92M -1.39M
Total cashflows from investing activities -0.04M -2.85M -2.64M -5.92M -1.39M
Net borrowings -2.16M 10.31M 4.47M 4.46M -0.09M
Total cash from financing activities -1.39M 10.72M 3.46M 4.41M -1.93M
Net income -27.54M 12.60M 10.55M 12.77M 10.18M
Change in cash -2.40M 1.46M -0.20M -1.32M 1.96M
Begin period cash flow 2.97M 1.51M 1.71M 3.03M 1.07M
End period cash flow 0.57M 2.97M 1.51M 1.71M 3.03M
Total cash from operating activities -1.34M -6.31M -1.02M 0.49M 5.26M
Issuance of capital stock 0.00M 2.90M 0.00M 0.00M -
Depreciation 1.10M 1.51M 1.38M 1.47M 1.40M
Other cashflows from investing activities - - - -0.01M 0.00M
Dividends paid - - - 0.00M 5.43M
Change to inventory 0.26M -0.19M 0.11M 1.57M -2.20M
Change to account receivables 5.35M -17.80M -9.67M -14.10M -3.49M
Other cashflows from financing activities 0.76M -2.49M 1.11M -0.05M 3.59M
Capital expenditures 0.04M 2.85M 2.64M 5.95M 1.39M
Change in working capital 6.79M -21.70M -14.05M -14.05M -6.57M
Stock based compensation 17.47M - - - -
Other non cash items 0.88M 1.25M 1.11M 0.43M 0.29M
Free cash flow -1.39M -9.17M -3.66M -5.47M 3.87M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
BDMD
Baird Medical Investment Holdings Limited		 0.05
44.36%		 0.16 - 7.57 1.38 0.97 1.95 133.58
ABT
Abbott Laboratories		 -1.91
1.65%		 113.60 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC		 -0.12
0.11%		 104.84 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation		 -4.61
1.36%		 335.04 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG		 1.24
2.45%		 52.00 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

Baird Medical Investment Holdings Limited

Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; and long and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, and uterine fibroids, as well as soft tissue ablation. It sells its products through third-party distributors. It has a strategic cooperation agreement with Tianjin Yuanshan Medical Technology Co., Ltd. to focus on global development and commercialization of next-generation IRE technologies. Baird Medical Investment Holdings Limited was founded in 2012 and is based in Guangzhou, China.

Baide Building, Building 11, Guangzhou, China

86 20 8218 5926

https://bairdmed.com

146

Name Title Year Born
Ms. Haimei Wu Chairwoman of the Board of Directors & CEO 1982
Ms. Quan Qiu Chief Administrative Officer & Executive Director 1993
Mr. Wei Hou Executive Director 1970
Ms. Jie Li Acting Chief Financial Officer 1988
Mr. Rongjian Lu CTO & Deputy GM 1967
Mr. Mark S. Saxton Chief Executive Officer U.S. Subsidiary 1965

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DHT-U
CAD 13.53
+16.44%
LIF
CAD 22.04
+8.62%
TOI
CAD 103.80
+7.09%
CRON
CAD 5.26
+6.69%
CIA
CAD 2.04
+6.25%
ITH
CAD 1.61
-34.02%
IFOS
CAD 1.65
-22.90%
TNZ
CAD 49.70
-19.58%
KEEL
CAD 2.36
-19.45%
GIL
CAD 49.36
-18.33%

Equity Sectors*

  • Basic Materials

    -2.18%

  • Communication Services

    +0.95%

  • Consumer Cyclical

    -2.25%

  • Consumer Defensive

    -0.68%

  • Energy

    -2.93%

  • Financial Services

    -2.26%

  • Healthcare

    -0.46%

  • Industrials

    -3.70%

  • Real Estate

    -0.06%

  • Technology

    -3.32%

  • Utilities

    -0.50%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…